Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
282.5 INR | -0.98% | -3.65% | -10.73% |
Mar. 15 | Gufic Biosciences Secures Patent in India | MT |
Feb. 16 | Transcript : Gufic Biosciences Limited, Q3 2024 Earnings Call, Feb 16, 2024 |
Sales 2022 | 7.79B 93.49M | Sales 2023 | 6.91B 82.87M | Capitalization | 18.09B 217M |
---|---|---|---|---|---|
Net income 2022 | 958M 11.5M | Net income 2023 | 797M 9.56M | EV / Sales 2022 | 3.16 x |
Net Debt 2022 | 528M 6.33M | Net Debt 2023 | 3.06B 36.67M | EV / Sales 2023 | 3.06 x |
P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
22.7
x | Employees | 1,628 |
Yield 2022 |
0.04% | Yield 2023 |
0.05% | Free-Float | 21.37% |
Latest transcript on Gufic Biosciences Limited
1 day | -0.98% | ||
1 week | -3.65% | ||
Current month | -10.33% | ||
1 month | -8.71% | ||
3 months | -10.78% | ||
6 months | -1.48% | ||
Current year | -10.73% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 41 | 04-06-24 | |
Chief Executive Officer | - | 99-08-30 | |
Director of Finance/CFO | - | 18-10-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 99-08-30 | |
Chief Executive Officer | 41 | 04-06-24 | |
Director/Board Member | 64 | 86-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 282.5 | -0.98% | 85 594 |
24-03-27 | 285.3 | -2.08% | 131,244 |
24-03-26 | 291.4 | -2.05% | 80,552 |
24-03-22 | 297.4 | +1.45% | 53,869 |
24-03-21 | 293.2 | +1.30% | 96,122 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+1.02% | 210B | |
+2.77% | 210B | |
-6.56% | 201B | |
-3.51% | 157B |
- Stock
- Equities
- Stock Gufic Biosciences Limited
- Stock Gufic Biosciences Limited - NSE India S.E.